NO3083605T3 - - Google Patents

Info

Publication number
NO3083605T3
NO3083605T3 NO14827909A NO14827909A NO3083605T3 NO 3083605 T3 NO3083605 T3 NO 3083605T3 NO 14827909 A NO14827909 A NO 14827909A NO 14827909 A NO14827909 A NO 14827909A NO 3083605 T3 NO3083605 T3 NO 3083605T3
Authority
NO
Norway
Application number
NO14827909A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3083605T3 publication Critical patent/NO3083605T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41521,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
NO14827909A 2013-12-19 2014-12-11 NO3083605T3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2013/089987 WO2015089800A1 (en) 2013-12-19 2013-12-19 Fluorophenyl pyrazol compounds
PCT/US2014/069785 WO2015094913A1 (en) 2013-12-19 2014-12-11 Fluorophenyl pyrazol compounds

Publications (1)

Publication Number Publication Date
NO3083605T3 true NO3083605T3 (no) 2018-07-21

Family

ID=52355187

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14827909A NO3083605T3 (no) 2013-12-19 2014-12-11

Country Status (23)

Country Link
US (1) US9499490B2 (no)
EP (1) EP3083605B1 (no)
JP (1) JP6190067B2 (no)
KR (1) KR101827660B1 (no)
CN (1) CN105814039B (no)
AU (1) AU2014366436B2 (no)
BR (1) BR112016011778A8 (no)
CA (1) CA2929563C (no)
DK (1) DK3083605T3 (no)
EA (1) EA029058B1 (no)
ES (1) ES2664418T3 (no)
HR (1) HRP20180618T1 (no)
HU (1) HUE039102T2 (no)
LT (1) LT3083605T (no)
MX (1) MX2016007985A (no)
NO (1) NO3083605T3 (no)
PL (1) PL3083605T3 (no)
PT (1) PT3083605T (no)
RS (1) RS57071B1 (no)
SA (1) SA516371323B1 (no)
SI (1) SI3083605T1 (no)
TR (1) TR201802981T4 (no)
WO (2) WO2015089800A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3336B1 (ar) 2014-10-07 2019-03-13 Lilly Co Eli مركبات أمينو بيريديلوكسي بيرازول
CN106795120B (zh) * 2014-10-31 2020-09-01 豪夫迈·罗氏有限公司 新的吡啶基氧基-和苯基氧基-吡唑基化合物
WO2016131198A1 (en) 2015-02-18 2016-08-25 Eli Lilly And Company Pyrazole compounds
WO2016201662A1 (en) * 2015-06-18 2016-12-22 Eli Lilly And Company Fluoropyridyl pyrazol compounds
CN109096194B (zh) * 2018-10-09 2022-02-08 湖南师范大学 一种双胍衍生物、药物组合物、制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7989400A (en) * 1999-10-01 2001-05-10 Smithkline Beecham Corporation Compounds and methods
WO2002000651A2 (en) 2000-06-27 2002-01-03 Bristol-Myers Squibb Pharma Company Factor xa inhibitors
EP1379241A1 (en) * 2001-03-29 2004-01-14 SmithKline Beecham Corporation Compounds and methods
WO2003031434A1 (en) * 2001-10-12 2003-04-17 Smith Kline Beecham Corporation Compounds and methods
AU2002359694A1 (en) * 2001-12-14 2003-06-30 Smithkline Beecham Corporation Compounds and methods
MXPA05000200A (es) 2002-07-02 2005-06-06 Schering Corp Nuevos antagonistas del receptor neuropeptido y y5.
US7253204B2 (en) 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
DE102004049078A1 (de) * 2004-10-08 2006-04-13 Merck Patent Gmbh Phenylpyrazole
US20120010290A1 (en) * 2008-12-04 2012-01-12 Vath James E Methods of Treating an Overweight or Obese Subject
TW201245155A (en) 2010-09-01 2012-11-16 Du Pont Fungicidal pyrazoles
WO2012090219A2 (en) 2010-12-31 2012-07-05 Jubilant Biosys Ltd. Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors
WO2012149236A1 (en) * 2011-04-28 2012-11-01 Bristol-Myers Squibb Company Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
JO3336B1 (ar) 2014-10-07 2019-03-13 Lilly Co Eli مركبات أمينو بيريديلوكسي بيرازول

Also Published As

Publication number Publication date
PT3083605T (pt) 2018-03-01
AU2014366436A1 (en) 2016-05-19
RS57071B1 (sr) 2018-06-29
BR112016011778A8 (pt) 2018-01-30
KR20160075827A (ko) 2016-06-29
HRP20180618T1 (hr) 2018-07-13
CN105814039A (zh) 2016-07-27
TR201802981T4 (tr) 2018-03-21
JP2016540801A (ja) 2016-12-28
MX2016007985A (es) 2016-09-09
CA2929563A1 (en) 2015-06-25
HUE039102T2 (hu) 2018-12-28
SA516371323B1 (ar) 2018-04-24
AU2014366436B2 (en) 2017-08-24
EP3083605A1 (en) 2016-10-26
PL3083605T3 (pl) 2018-07-31
US20160289195A1 (en) 2016-10-06
EA029058B1 (ru) 2018-02-28
WO2015094913A1 (en) 2015-06-25
US9499490B2 (en) 2016-11-22
EP3083605B1 (en) 2018-02-21
CA2929563C (en) 2018-05-15
CN105814039B (zh) 2018-07-17
DK3083605T3 (en) 2018-03-12
EA201690924A1 (ru) 2016-09-30
WO2015089800A1 (en) 2015-06-25
ES2664418T3 (es) 2018-04-19
KR101827660B1 (ko) 2018-02-08
LT3083605T (lt) 2018-04-10
SI3083605T1 (en) 2018-04-30
JP6190067B2 (ja) 2017-08-30
BR112016011778A2 (pt) 2017-08-08

Similar Documents

Publication Publication Date Title
AP2016009275A0 (no)
BR112015007533A2 (no)
BR102016010778A2 (no)
BR112014017733A2 (no)
BR112014017739A2 (no)
BR112014018502A2 (no)
BR112014019326A2 (no)
BR112014018516A2 (no)
BR112014017765A2 (no)
BR112014017855A2 (no)
BR112014017669A2 (no)
BR112014019204A2 (no)
BR112015016283A2 (no)
BR112015015948A2 (no)
BR112014017722A2 (no)
BR112014018578A2 (no)
BR112014017653A2 (no)
BR112014017794A2 (no)
BR112014017601A2 (no)
BR112015015312A2 (no)
BR112016011770A2 (no)
BR112016000609A2 (no)
BR112014018496A2 (no)
BR112014018514A2 (no)
BR112014017745A2 (no)